At a glance
ClinicalIndex Comparison RecordN/ACompleted· 121 enrolled
Drug / intervention
Procalcitonin-guided decision makingother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Use of Procalcitonin-Guided Decision Making to Shorten Antibiotic Therapy in Suspected Neonatal Early-Onset Sepsis: Prospective Randomized Intervention Trial
In Brief
A clinical study evaluating Procalcitonin-guided decision making for Sepsis. Completed, enrolled 121 participants across 1 site.
Detailed Summary
Neonatal bacterial sepsis is a major cause of mortality and morbidity and early antibiotic therapy is crucial for treatment success. Objective: To evaluate the effect of Procalcitonin-guided decision making on duration opf antibiotic therapy in suspected neonatal early-onset sepsis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSepsis
CountriesSwitzerland
Collaborators--
Timeline
N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJun 2005
Primary CompletionDec 2006
Study CompletionJan 2007
First PostedJun 2009
TodayJul 2026
First PostedJun 23, 2009
Enrollment StartJun 1, 2005
Primary CompletionDec 1, 2006
Study CompletionJan 1, 2007
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 17.0 years ago
Interventions
Procalcitonin-guided decision makingother
Procalcitonin-guided decision making on duration of antibiotic therapy in suspected neonatal early onset sepsis